A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

In an effort to combat Alzheimer's disease, scientists are looking at existing drugs that could treat the condition, and a ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Medically reviewed by Smita Patel, DO Some commonly used medications have been linked to memory issues and severe ...

Washington University Medicine in St. Louis is conducting important research into treating early-onset Alzheimer's before ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

UTICA — Kinney Drugs has partnered with the Alzheimer’s Association to present a free public webinar aimed at raising ...

Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking ...

A new study offers a concrete, testable explanation for why Alzheimer’s patients often stop recognizing their loved ones.